Lyra Therapeutics logo

Lyra Therapeutics Share Price Today

(NASDAQ: LYRA)

Lyra Therapeutics share price is $0.09 & ₹7.69 as on 18 Apr 2025, 2.30 'hrs' IST

$0.09

-0.01

(-5.98%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Lyra Therapeutics share price in Dollar and Rupees. Guide to invest in Lyra Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Lyra Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Lyra Therapeutics share price movements

  • Today's Low: $0.09
    Today's High: $0.10

    Day's Volatility :10.69%

  • 52 Weeks Low: $0.08
    52 Weeks High: $5.65

    52 Weeks Volatility :98.55%

Lyra Therapeutics (LYRA) Returns

PeriodLyra Therapeutics IncIndex (Russel 2000)
3 Months
-55.06%
0.0%
6 Months
-64.55%
0.0%
1 Year
-98.33%
0.0%
3 Years
-98.4%
-12.9%

Lyra Therapeutics (LYRA) Key Statistics

in dollars & INR

Previous Close
$0.092
Open
$0.095
Today's High
$0.095175
Today's Low
$0.085
Market Capitalization
$6.1M
Today's Volume
$1.2M
52 Week High
$5.65
52 Week Low
$0.082
Revenue TTM
$1.5M
EBITDA
$-60.3M
Earnings Per Share (EPS)
$-1.43
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-184.99%

How to invest in Lyra Therapeutics Stock (LYRA) from India?

It is very easy for Indian residents to invest directly in Lyra Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Lyra Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Lyra Therapeutics or LYRA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Lyra Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Lyra Therapeutics shares which would translate to 9.496 fractional shares of Lyra Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Lyra Therapeutics, in just a few clicks!

Returns in Lyra Therapeutics (LYRA) for Indian investors in Rupees

The Lyra Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Lyra Therapeutics investment value today

Current value as on today

₹4,075

Returns

₹95,925

(-95.92%)

Returns from Lyra Therapeutics Stock

₹98,266 (-98.27%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Lyra Therapeutics (LYRA)

-10%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Lyra Therapeutics Stock from India on INDmoney has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Lyra Therapeutics

  • Perceptive Advisors LLC

    19.36%

  • BlackRock Inc

    4.72%

  • Samsara BioCapital, LLC

    2.98%

  • Vanguard Group Inc

    2.71%

  • Ikarian Capital, LLC

    1.61%

  • Geode Capital Management, LLC

    1.34%

Analyst Recommendation on Lyra Therapeutics

Rating
Trend

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Lyra Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Lyra Therapeutics Stock (LYRA)

What analysts predicted

Upside of 1288.89%

Target:

$1.25

Current:

$0.09

Insights on Lyra Therapeutics Stock (Ticker Symbol: LYRA)

  • Price Movement

    In the last 7 days, LYRA stock has moved down by -10.0%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 195.0K → 209.0K (in $), with an average increase of 6.7% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -48.13M → -10.97M (in $), with an average increase of 156.8% per quarter
  • LYRA vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 174.3%
  • LYRA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 127.2%
  • Price to Sales

    ForLYRA every $1 of sales, investors are willing to pay $3.6, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Lyra Therapeutics Technicals Summary

Sell

Neutral

Buy

Lyra Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Lyra Therapeutics (LYRA) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Lyra Therapeutics Inc logo
-44.78%
-64.55%
-98.33%
-98.4%
-99.53%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Lyra Therapeutics

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis. Its technology is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix which is in Phase III clinical trial for the treatment of chronic rhinosinusitis (CRS); and LYR-220 for CRS patients who have failed previous medical management and continue to require treatment to manage CRS symptoms. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.
Organization
Lyra Therapeutics
Employees
30
CEO
Dr. Maria Palasis Ph.D.
Industry
Health Technology

Management People of Lyra Therapeutics

NameTitle
Dr. Harlan W. Waksal M.D.
Executive Chairman
Dr. Maria Palasis Ph.D.
CEO, President & Director
Mr. Jason Cavalier
CFO, Treasurer & Secretary
Dr. Carmichael S. Roberts Jr., Ph.D.
Co-Founder
Mr. Ronan P. O'Brien J.D.
Chief Legal Officer
Ms. Vineeta Belanger Ph.D.
Senior Vice President of Clinical Affairs
Dr. Robert Kern M.D.
Chief Clinical Advisor
Ms. Gloria Cosgrove
Senior Vice President of Quality
Ms. Allison Nance
Senior Vice President of Regulatory Affairs
Dr. Elazer R. Edelman FACC, M.D., Ph.D.
VP of Finance & Risk

Important FAQs about investing in LYRA Stock from India :

What is Lyra Therapeutics share price today?

Lyra Therapeutics share price today stands at $0.09, Open: $0.10 ; Previous Close: $0.09 ; High: $0.10 ; Low: $0.09 ; 52 Week High: $5.65 ; 52 Week Low: $0.08.

The stock opens at $0.10, after a previous close of $0.09. The stock reached a daily high of $0.10 and a low of $0.09, with a 52-week high of $5.65 and a 52-week low of $0.08.

Can Indians buy Lyra Therapeutics shares?

Yes, Indians can invest in the Lyra Therapeutics (LYRA) from India.

With INDmoney, you can buy Lyra Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Lyra Therapeutics at zero transaction cost.

How can I buy Lyra Therapeutics shares from India?

It is very easy to buy Lyra Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lyra Therapeutics (LYRA) be purchased?

Yes, you can buy fractional shares of Lyra Therapeutics with INDmoney app.

What are the documents required to start investing in Lyra Therapeutics stocks?

To start investing in Lyra Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Lyra Therapeutics Stock (LYRA)?

Today’s highest price of Lyra Therapeutics (LYRA) is $0.10.

Today’s lowest price of Lyra Therapeutics (LYRA) is $0.09.

What is today's market capitalisation of Lyra Therapeutics?

Today's market capitalisation of Lyra Therapeutics LYRA is 6.1M

What is the 52 Week High and Low Range of Lyra Therapeutics Stock (LYRA)?

  • 52 Week High

    $5.65

  • 52 Week Low

    $0.08

What are the historical returns of Lyra Therapeutics (LYRA)?

  • 1 Month Returns

    -44.78%

  • 3 Months Returns

    -64.55%

  • 1 Year Returns

    -98.33%

  • 5 Years Returns

    -99.53%

Who is the Chief Executive Officer (CEO) of Lyra Therapeutics ?

Dr. Maria Palasis Ph.D. is the current Chief Executive Officer (CEO) of Lyra Therapeutics.